| | | | | | | | | | |
|
|
| Dockets Entered
On January 31, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
| 2004D-0555
|
| Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
|
|
|
| 2004N-0556
|
| Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
|
|
|
| 2005D-0481
|
| Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
|
|
|
|
|
|
| 2005P-0267
|
| Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
17197
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17198
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17199
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17200
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17201
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17202
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17203
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17204
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17205
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17206
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17207
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17208
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17209
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17210
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17211
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17212
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17213
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17214
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17215
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17216
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17217
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17218
|
| Enzymatic Therapy
|
| Vol #:
|
| 157
|
|
|
| LET
17219
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17220
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17221
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17222
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
| | | | | | | | |
|
|
| LET
17223
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17224
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17225
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17226
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17227
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17228
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17229
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17230
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17231
|
| Enzymatic Therapy
|
| Vol #:
|
| 158
|
|
|
| LET
17232
|
| Iovate Health Sciences U.S.A. Inc.
|
| Vol #:
|
| 158
|
|
|
| LET
17233
|
| Iovate Health Sciences U.S.A. Inc.
|
| Vol #:
|
| 158
|
|
|
| LET
17234
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17235
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17236
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17237
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17238
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17239
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17240
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17241
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17242
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17243
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17244
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| LET
17245
|
| Beulah Land Corporation
|
| Vol #:
|
| 158
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
| C 18247
|
| M. Yahres
|
| Vol #:
|
| 516
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
| C 12841
|
| M. Yahres
|
| Vol #:
|
| 806
|
|
|
| 2004D-0555
|
| Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
|
|
|
| C
4
|
| American Society for Reproductive Medicine (ASRM)
|
| Vol #:
|
| 1
|
|
|
| 2004N-0556
|
| Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
|
|
|
| C
1
|
| American Society for Reproductive Medicine (ASRM)
|
| Vol #:
|
| 1
|
|
|
| 2005D-0481
|
| Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
|
|
|
|
|
|
|
| C 1
|
| B. Wagner, JD, MPH, REHS
|
| Vol #:
|
| 1
|
|